NCT00070096View on ClinicalTrials.gov

Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors

PHASE2CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

August 31, 2003

Study Completion Date

June 30, 2007

Conditions
Brain and Central Nervous System TumorsExtragonadal Germ Cell TumorOvarian CancerTesticular Germ Cell Tumor
Interventions
DRUG

ixabepilone

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00070096 - Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors | Biotech Hunter | Biotech Hunter